Physician profile
Prejesh Philips
NPI 1114183787
$8,824.08
in general payments reported to CMS, 2019-2025
34 companies · $1,388 in 2025
The $1,388 reported for 2025 was more than what 75% of Surgical Oncology providers received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,852 · 2020: $381 · 2021: $305 · 2022: $526 · 2023: $729 · 2024: $1,644 · 2025: $1,388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,308 · Travel and Lodging: $1,453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,307.69 |
| Travel and Lodging | $1,453.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,444.35 | 2019-2025 | Axios, Overstitch Endoscopic Suturing System, Exalt Model D |
| Intuitive Surgical, INC. | $2,129.97 | 2019 | |
| Asensus Surgical, INC. | $1,079.45 | 2019 | |
| Abbvie INC. | $355.74 | 2021-2025 | |
| Angiodynamics, INC. | $251.95 | 2022-2024 | Solero |
| Medtronic, INC. | $244.30 | 2022-2023 | Signia, Emprint |
| Dilon Technologies, INC. | $166.14 | 2024 | Hemoblast Bellows |
| Karl Storz Endoscopy-America | $149.09 | 2023 | Image1 S Connect |
| E.R. Squibb & Sons, L.L.C. | $124.74 | 2022 | |
| Ethicon US, LLC | $114.20 | 2020 | |
| Apollo Endosurgery US INC | $95.40 | 2023 | Overstitch Endoscopic Suturing System |
| Avita Medical Americas, LLC | $91.98 | 2025 | Permeaderm, Recell, Cohealyx |
| Amgen INC. | $64.43 | 2019 | |
| W. L. Gore & Associates, INC. | $58.20 | 2020 | |
| Astellas Pharma US INC | $57.92 | 2023-2024 | Xospata, Vyloy |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $36.17 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Celgene Corporation | $35.29 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $27.29 | 2019-2020 | |
| Eisai INC. | $26.99 | 2020-2024 | |
| Tela Bio, INC. | $25.46 | 2020-2021 | |
| Alcresta Therapeutics, INC. | $24.68 | 2024 | Relizorb |
| Micro-Tech Endoscopy USA, INC. | $24.15 | 2024 | Eyemax |
| Taiho Oncology, INC. | $23.48 | 2025 | |
| Eagle Pharmaceuticals, INC. | $19.86 | 2024 | |
| Novartis Pharmaceuticals Corporation | $19.12 | 2020 | |
| Baudax Bio INC. | $18.00 | 2022 | |
| Merck Sharp & Dohme LLC | $16.65 | 2022 | |
| Janssen Biotech, INC. | $15.59 | 2025 | Erleada |
| Helsinn Therapeutics (U.S.), INC. | $14.96 | 2021 | |
| Avanos Medical | $14.71 | 2019 | |
| Axonics, INC. | $14.37 | 2022 | |
| Advanced Accelerator Applications | $14.17 | 2019 | |
| Acera Surgical, INC. | $13.28 | 2023 | Restrata Wound Matrix |
| Incyte Corporation | $12.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prejesh Philips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.